South America Bone Cement Market

The SAM bone cement market is expected to grow from US$ 68.38 million in 2021 to US$ 97.94 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028.

The rising demand for kyphoplasty, arthroplasty, and vertebroplasty surgeries is expected to increase the sales of bone cement. Leading market players across the region are increasing their penetration across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Emerging markets across the region are expected to offer potential growth opportunities for key bone cement manufacturers in the years to come. This can be attributed to the rise in the aging population, high prevalence of osteoporosis, increased disposable income, improved healthcare infrastructure, and growth of medical tourism in several countries. Several emerging countries across the region have become business-friendly and adaptable hubs due to relatively less stringent regulations and data requirements. Most players are shifting their focus to emerging markets. High investments in life science and health research in emerging countries play a key role in upgrading the latest technologies in these countries. This factor, in turn, supports the inclination toward bone cement use, thereby driving the SAM market.

A considerable number of countries in South America have very underdeveloped healthcare infrastructure. For instance, Peru has less than 1,000 intensive care unit beds for its 32 million inhabitants. Despite the facts mentioned above, SAM is positively impacted by COVID-19. Researchers have been studying alternatives to detect SARS-CoV-2 (COVID-19), and accurate and timely diagnosis is crucial for controlling the outbreaks of the disease. Like many countries worldwide, the Argentine government took extreme steps to protect citizens from vulnerability to COVID-19, the disease induced by the novel coronavirus. The COVID-19 pandemic generated the need for postponing elective surgery of the SUS, such as total hip and knee arthroplasty. As a result, in the first semester of 2020, there was a 67% decrease in the number and cost of knee and hip arthroplasty. This resulted in a financial loss for implant manufacturers, and it will drive the demand for additional procedures in the following months and years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM bone cement market. The SAM bone cement market is expected to grow at a good CAGR during the forecast period.       

SAM Bone Cement Market Revenue and Forecast to 2028 (US$ Million)
 

SAM Bone Cement Market Segmentation
   

SAM Bone Cement Market – by Type

• Polymethyl Methacrylate Cement (PMMA)
• Calcium Phosphate Cement (CPC)
• Glass Polyalkenoate Cement (GPC)
• Others

SAM Bone Cement Market – by Application

• Arthroplasty
• Kyphoplasty   
• Vertebroplasty

SAM Bone Cement Market – by End User

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Clinics

SAM Bone Cement Market, by Country

• Brazil
• Argentina
• Rest of SAM

SAM Bone Cement Market - Companies Mentioned

• Arthrex, Inc.
• Cardinal Health Inc.
• DePuy Synthes (The Orthopedics Company of Johnson & Johnson)
• DJO Global, Inc.
• Heraeus Holding GmbH  
• Smith & Nephew  
• Stryker Corporation 
• Tecres S.p.A.
• Teknimed
• Zimmer Biomet

South America Bone Cement Market Strategic Insights

South America Bone Cement Market Segmentation Analysis

South America Bone Cement Market Report Highlights

South America Bone Cement Report Scope

South America Bone Cement Market Country and Regional Insights